ST
CRMD icon

Spot Trading’s CorMedix CRMD Stock Holding History

Spot Trading’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-17,487
Closed -$134K – 2967
2016
Q4 		$134K Buy
17,487
+3,567
+26% +$36.1K ﹤0.01% 2093
2016
Q3 		$175K Buy
+13,920
New +$130K ﹤0.01% 2158
2016
Q2 		– Sell
-2,026
Closed -$27K – 3374
2016
Q1 		$27K Sell
2,026
-23,260
-92% -$226K ﹤0.01% 2970
2015
Q4 		$257K Buy
25,286
+5,189
+26% +$59.7K ﹤0.01% 2328
2015
Q3 		$200K Buy
20,097
+12,282
+157% +$189K ﹤0.01% 2691
2015
Q2 		$152K Buy
+7,815
New +$268K ﹤0.01% 2867

Other funds holding CRMD

EM
Elliott Management New York $11.8B AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.29B AUM 4.86% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GLRA
Gerald L. Ray & Associates Dallas, Texas $802M AUM 21.01% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $71.1B AUM 128.96% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return

Spot Trading's CRMD Position: Q1 2017 in Review

Spot Trading sold out of CorMedix (CRMD) in Q1 2017, closing a stake of 17,487 shares — an estimated $134K sold.

Spot Trading first reported a position in CRMD in Q2 2015 and held it in 6 quarters. The position peaked at $257K in Q4 2015. 30 funds tracked by Wall St. Rank hold CRMD as of Q1 2017.

  • Spot Trading reported no remaining CorMedix position as of Q1 2017 after selling out during the quarter.
  • Spot Trading sold 17,487 CorMedix shares in Q1 2017, an estimated $134K.
  • Spot Trading first reported a position in CorMedix in Q2 2015 and held it in 6 quarters.
  • Spot Trading's CorMedix position peaked at $257K in Q4 2015.
  • 30 funds tracked by Wall St. Rank held CorMedix as of Q1 2017.

Based on Spot Trading's 13F filing for Q1 2017, filed 1 May 2017.